CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity

Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis

(2015) Beatrice Grabner et al.   Nature Communications

Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression

(2014) Chunxiao Xu et al.   CANCER CELL

Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells

(2014) Ho-June Lee et al.   CANCER CELL

Cell migration leads to spatially distinct but clonally related airway cancer precursors

(2014) Christodoulos P Pipinikas et al.   THORAX

Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma

(2014) Elizabeth K Sage et al.   THORAX

HPV-positive oropharyngeal squamous cell carcinoma is associated withTIMP3andCADM1promoter hypermethylation

(2014) Pauline M. W. van Kempen et al.   Cancer Medicine

Treatment Paradigms for Patients with Metastatic Non-Small Cell Lung Cancer, Squamous Lung Cancer: First, Second, and Third-Line

(2014) Abdulaziz Al-Farsi et al.   Frontiers in Oncology

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

miR-214 and hypoxia down-regulate Necl-2/CADM1 and enhance ErbB2/ErbB3 signaling

(2013) Kenji Momose et al.   GENES TO CELLS

MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines

(2013) A Vultur et al.   ONCOGENE

Immune Checkpoint Inhibitors: Making Immunotherapy a Reality for the Treatment of Lung Cancer

(2013) J. R. Brahmer et al.   Cancer Immunology Research

Spatiotemporal Regulation of Epithelial-Mesenchymal Transition Is Essential for Squamous Cell Carcinoma Metastasis

(2012) Jeff H. Tsai et al.   CANCER CELL

Activation of IL-6R/JAK1/STAT3 Signaling Induces De Novo Resistance to Irreversible EGFR Inhibitors in Non-Small Cell Lung Cancer with T790M Resistance Mutation

(2012) S. M. Kim et al.   MOLECULAR CANCER THERAPEUTICS

Comprehensive genomic characterization of squamous cell lung cancers

(2012)   NATURE

STAT3 negatively regulates thyroid tumorigenesis

(2012) J. P. Couto et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy

(2012) Malabika Sen et al.   Cancer Discovery

Cadm1 Is a Metastasis Susceptibility Gene That Suppresses Metastasis by Modifying Tumor Interaction with the Cell-Mediated Immunity

(2012) Farhoud Faraji et al.   PLoS Genetics

Interaction of Nectin-like Molecule 2 with Integrin α6β4and Inhibition of Disassembly of Integrin α6β4from Hemidesmosomes

(2011) Kiyohito Mizutani et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Epidermal Cadm1 Expression Promotes Autoimmune Alopecia via Enhanced T Cell Adhesion and Cytotoxicity

(2011) A. Giangreco et al.   JOURNAL OF IMMUNOLOGY

β-Catenin determines upper airway progenitor cell fate and preinvasive squamous lung cancer progression by modulating epithelial-mesenchymal transition

(2011) Adam Giangreco et al.   JOURNAL OF PATHOLOGY

Comprehensive CADM1 promoter methylation analysis in NSCLC and normal lung specimens

(2010) Remco M. van den Berg et al.   LUNG CANCER

TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214

(2010) G Yin et al.   ONCOGENE

Stat3 Is a Negative Regulator of Intestinal Tumor Progression in ApcMin Mice

(2009) Monica Musteanu et al.   GASTROENTEROLOGY

Silencing of ErbB3/ErbB2 Signaling by Immunoglobulin-like Necl-2

(2009) Satoshi Kawano et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Interplay of Cadherin-Mediated Cell Adhesion and Canonical Wnt Signaling

(2009) J. Heuberger et al.   Cold Spring Harbor Perspectives in Biology

Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation

(2008) Yoshimi Takai et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY